MAAT PHARMA | WebDisclosure

Basculer en Français

10817	Companies
234430	Keywords
163287	Articles
125437	Press releases

Home
Companies
MAAT PHARMA

PRESS RELEASE

published on 11/19/2025 at 11:11, 8 months 21 days ago

Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research updates BUY recommendation for MaaT Pharma SACA, citing successful €9.1m capital raise with strong investor support for lead drug Xervyteg. Company well-positioned for commercialization

First Berlin Equity Research Capital Increase Investment Advice Xervyteg MaaT Pharma SACA
PRESS RELEASE

published on 11/19/2025 at 08:41, 8 months 21 days ago

Rapport Financier Semestriel 2025
PRESS RELEASE

published on 11/18/2025 at 12:52, 8 months 22 days ago

Rapport Financier Semestriel 2025
PRESS RELEASE

published on 11/18/2025 at 12:48, 8 months 22 days ago

Rapport Semestriel 2025
BRIEF

published on 11/14/2025 at 23:10, 8 months 26 days ago

MaaT Pharma: successful fundraising of 9.1 million euros

Investors Biotechnology Fundraising Microbiome Medical Innovation
BRIEF

published on 11/14/2025 at 23:10, 8 months 26 days ago

MaaT Pharma : levée de fonds réussie de 9,1 millions d'euros

Biotechnologie Innovation Médicale Investisseurs Microbiome Levée De Fonds
PRESS RELEASE

published on 11/14/2025 at 23:05, 8 months 26 days ago

Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
MaaT Pharma annonce le succès de son Offre Globale de 9,1 millions d'euros pour le développement de Microbiome Ecosystem Therapies™. Levée de fonds pour Xervyteg® et MaaT033

Microbiome Ecosystem Therapies Offre Globale MaaT Pharma MaaT033 Xervyteg
PRESS RELEASE

published on 11/14/2025 at 23:05, 8 months 26 days ago

Inside Information / Operations of the issuer (acquisitions, sales...)
MaaT Pharma successfully completes Global Offering of €9.1 million, strengthening financial position and supporting development of Microbiome Therapies for cancer patients

Financial Position Global Offering MaaT Pharma Cancer Patients Microbiome Therapies
BRIEF

published on 11/13/2025 at 19:45, 8 months 27 days ago

Lancement d'une augmentation de capital par MaaT Pharma

Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
BRIEF

published on 11/13/2025 at 19:45, 8 months 27 days ago

MaaT Pharma launches a capital increase

Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing

Accesswire

Published on 08/11/2026 at 00:40, 2 hours 51 minutes ago

CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 3 hours 6 minutes ago

Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 3 hours 56 minutes ago

NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 4 hours 1 minute ago

Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 4 hours 6 minutes ago

Ur-Energy Reports Second Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 22:15, 5 hours 16 minutes ago

Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 5 hours 26 minutes ago

Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 7 hours 7 minutes ago

EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 7 hours 56 minutes ago

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 8 hours 31 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026

Les Echos

Published on 08/10/2026 at 18:00, 9 hours 31 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 9 hours 31 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 9 hours 46 minutes ago

Weekly share buyback
Published on 08/10/2026 at 17:45, 9 hours 46 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 15 hours 38 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

View all LES ECHOS COMFI WIRE